[14] To evaluate biliary strictures of undetermined etiology, the efficacies of variable diagnostic impetuses such as tumor markers, radiological evaluations, endoscopic approaches and tissue ...

Scientists have discovered a novel subset of cancer-fighting immune cells that reside outside of their normal neighborhood -- known as the tertiary lymphoid structure -- where they become ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...

After one year, a test showed that his blood cancer markers had begun to rise, but a CT scan showed no signs of tumors. In spring 2024, a follow-up CT scan showed that Maclean had a significant ...

Lessons From Taxanes Versus Eribulin for First-Line Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the EMERALD Study ASCO Guidelines provide recommendations with ...

Over the last years, many biological markers emerged that act as an adjunct for the detection of early bladder cancer recurrence. Some of these markers had a proven better sensitivity and ...

Deregulation of secreted mucin 2 (MUC2) production has provided an important link between inflammation and cancer ... Mucins have thus been identified as markers of adverse prognosis and as ...

College of Materials Science and Engineering, Huaqiao University, Xiamen 361021, China School of Resources and Civil Engineering, Gannan University of Science and Technology, Ganzhou 341000, China ...

Tumour biomarkers is a term used to describe many different potential markers of cancer development and progression. These markers can come in many forms for example, proteins, biochemicals, ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...